Skip to main content
Top
Published in: Acta Neuropathologica 5/2010

01-11-2010 | Case Report

Nodular bilateral amygdala degeneration in demented individuals

Authors: Aurelio Hernandez Lain, Andrew P. Lieberman, Rolf Pfannl, E. Tessa Hedley-Whyte

Published in: Acta Neuropathologica | Issue 5/2010

Login to get access

Abstract

Among more than 2,050 brains in our Alzheimer disease brain banks, we came across three brains with well-demarcated indurated white-yellow nodules in the amygdalas. Microscopically, these nodules were composed of numerous lipid-laden macrophages located in the central region surrounded by an eosinophilic hyaline-like material with minimal reactive gliosis in the periphery. Neurons within these lesions had a normal appearance but were moderately decreased in number. Beta-amyloid, tau and alpha-synuclein immunostaining revealed no abnormal deposits within the nodules. The three patients had long histories of dementia (one linked to a presenilin-1 mutation). The neuropathological diagnoses were Alzheimer disease in two of them and an unclassified tauopathy with argyrophilic grains in the third. In conclusion, the pathogenesis of these lesions is uncertain. We favor that the degeneration has some relationship to the underlying dementing disease, either secondary to deafferentation or an alteration in metabolic demand, perhaps related to the bi-directional anatomical and functional connections that exist between the amygdala and the hippocampus or less likely as a primary event.
Literature
1.
go back to reference Auer RN, Siesjö BK (1988) Biological differences between ischemia, hypoglycemia, and epilepsy. Ann Neurol 24:699–707CrossRefPubMed Auer RN, Siesjö BK (1988) Biological differences between ischemia, hypoglycemia, and epilepsy. Ann Neurol 24:699–707CrossRefPubMed
2.
go back to reference Brashear HR, Godec MS, Carlsen J (1988) The distribution of neuritic plaques and acetylcholinesterase staining in the amygdala in Alzheimer’s disease. Neurology 38:1694–1699PubMed Brashear HR, Godec MS, Carlsen J (1988) The distribution of neuritic plaques and acetylcholinesterase staining in the amygdala in Alzheimer’s disease. Neurology 38:1694–1699PubMed
3.
go back to reference Broks P, Young AW, Maratos EJ et al (1998) Face processing impairments after encephalitis: amygdala damage and recognition of fear. Neuropsychologia 36:59–70CrossRefPubMed Broks P, Young AW, Maratos EJ et al (1998) Face processing impairments after encephalitis: amygdala damage and recognition of fear. Neuropsychologia 36:59–70CrossRefPubMed
4.
go back to reference De Martino B, Camerer CF, Adolphs R (2010) Amygdala damage eliminates monetary loss aversion. Proc Natl Acad Sci USA 107:3788–3792CrossRefPubMed De Martino B, Camerer CF, Adolphs R (2010) Amygdala damage eliminates monetary loss aversion. Proc Natl Acad Sci USA 107:3788–3792CrossRefPubMed
5.
go back to reference Duyckaerts C, Derouesne C, Signoret JL, Gray F, Escourolle R, Castaigne P (1985) Bilateral and limited amygdalohippocampal lesions causing a pure amnesic syndrome. Ann Neurol 18:314–319CrossRefPubMed Duyckaerts C, Derouesne C, Signoret JL, Gray F, Escourolle R, Castaigne P (1985) Bilateral and limited amygdalohippocampal lesions causing a pure amnesic syndrome. Ann Neurol 18:314–319CrossRefPubMed
6.
go back to reference French SJ, Hailstone JC, Totterdell S (2003) Basolateral amygdala efferents to the ventral subiculum preferentially innervate pyramidal cell dendritic spines. Brain Res 981:160–167CrossRefPubMed French SJ, Hailstone JC, Totterdell S (2003) Basolateral amygdala efferents to the ventral subiculum preferentially innervate pyramidal cell dendritic spines. Brain Res 981:160–167CrossRefPubMed
7.
go back to reference Hamada T, McLean WH, Ramsay M et al (2002) Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1). Hum Mol Genet 11:833–840CrossRefPubMed Hamada T, McLean WH, Ramsay M et al (2002) Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1). Hum Mol Genet 11:833–840CrossRefPubMed
8.
go back to reference Hardy JA, Mann DM, Wester P, Winblad B (1986) An integrative hypothesis concerning the pathogenesis and progression of Alzheimer’s disease. Neurobiol Aging 7:489–502CrossRefPubMed Hardy JA, Mann DM, Wester P, Winblad B (1986) An integrative hypothesis concerning the pathogenesis and progression of Alzheimer’s disease. Neurobiol Aging 7:489–502CrossRefPubMed
9.
go back to reference Herzog AG, Kemper TL (1980) Amygdaloid changes in aging and dementia. Arch Neurol 37:625–629PubMed Herzog AG, Kemper TL (1980) Amygdaloid changes in aging and dementia. Arch Neurol 37:625–629PubMed
10.
go back to reference Kromer Vogt LJ, Hyman BT, Van Hoesen GW, Damasio AR (1990) Pathological alterations in the amygdala in Alzheimer’s disease. Neuroscience 37:377–385CrossRefPubMed Kromer Vogt LJ, Hyman BT, Van Hoesen GW, Damasio AR (1990) Pathological alterations in the amygdala in Alzheimer’s disease. Neuroscience 37:377–385CrossRefPubMed
11.
go back to reference Meenan FO, Bowe SD, Dinn JJ et al (1978) Lipoid proteinosis; a clinical, pathological and genetic study. Q J Med 47:549–561PubMed Meenan FO, Bowe SD, Dinn JJ et al (1978) Lipoid proteinosis; a clinical, pathological and genetic study. Q J Med 47:549–561PubMed
12.
go back to reference Meyer A, Beck E, Shepherd M (1955) Unusually severe lesions in the brain following status epilepticus. J Neurol Neurosurg Psychiatry 18:24–33CrossRefPubMed Meyer A, Beck E, Shepherd M (1955) Unusually severe lesions in the brain following status epilepticus. J Neurol Neurosurg Psychiatry 18:24–33CrossRefPubMed
13.
go back to reference Mirra SS, Heyman A, McKeel D et al (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486PubMed Mirra SS, Heyman A, McKeel D et al (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486PubMed
14.
go back to reference Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET (1999) Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer Disease. J Neuropathol Exp Neurol 58:1147–1155CrossRefPubMed Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET (1999) Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer Disease. J Neuropathol Exp Neurol 58:1147–1155CrossRefPubMed
15.
go back to reference Saunders RC, Rosene DL (1988) A comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey. I. Convergence in the entorhinal, prorhinal, and perirhinal cortices. J Comp Neurol 271:153–184CrossRefPubMed Saunders RC, Rosene DL (1988) A comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey. I. Convergence in the entorhinal, prorhinal, and perirhinal cortices. J Comp Neurol 271:153–184CrossRefPubMed
16.
go back to reference Saunders RC, Rosene DL, Van Hoesen GW (1988) Comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey. II. Reciprocal and non-reciprocal connections. J Comp Neurol 271:185–207CrossRefPubMed Saunders RC, Rosene DL, Van Hoesen GW (1988) Comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey. II. Reciprocal and non-reciprocal connections. J Comp Neurol 271:185–207CrossRefPubMed
17.
go back to reference Scott SA, DeKosky ST, Scheff SW (1991) Volumetric atrophy of the amygdala in Alzheimer’s disease: quantitative serial reconstruction. Neurology 41:351–356PubMed Scott SA, DeKosky ST, Scheff SW (1991) Volumetric atrophy of the amygdala in Alzheimer’s disease: quantitative serial reconstruction. Neurology 41:351–356PubMed
18.
go back to reference Siebert M, Markowitsch HJ, Bartel P (2003) Amygdala, affect and cognition: evidence from 10 patients with Urbach-Wiethe disease. Brain 126:2627–2637CrossRefPubMed Siebert M, Markowitsch HJ, Bartel P (2003) Amygdala, affect and cognition: evidence from 10 patients with Urbach-Wiethe disease. Brain 126:2627–2637CrossRefPubMed
19.
go back to reference Smith AP, Stephan KE, Rugg MD, Dolan RJ (2006) Task and content modulate amygdala-hippocampal connectivity in emotional retrieval. Neuron 49:631–638CrossRefPubMed Smith AP, Stephan KE, Rugg MD, Dolan RJ (2006) Task and content modulate amygdala-hippocampal connectivity in emotional retrieval. Neuron 49:631–638CrossRefPubMed
20.
go back to reference Vereecken TH, Vogels OJ, Nieuwenhuys R (1994) Neuron loss and shrinkage in the amygdala in Alzheimer’s disease. Neurobiol Aging 15:45–54CrossRefPubMed Vereecken TH, Vogels OJ, Nieuwenhuys R (1994) Neuron loss and shrinkage in the amygdala in Alzheimer’s disease. Neurobiol Aging 15:45–54CrossRefPubMed
21.
go back to reference Volpe BT, Petito CK (1985) Dementia with bilateral medial temporal lobe ischemia. Neurology 35:1793–1797PubMed Volpe BT, Petito CK (1985) Dementia with bilateral medial temporal lobe ischemia. Neurology 35:1793–1797PubMed
22.
go back to reference Vonsattel JPG, Aizawa H, Ge P et al (1995) An improved approach to prepare human brains for research. J Neuropathol Exp Neurol 54:42–56CrossRefPubMed Vonsattel JPG, Aizawa H, Ge P et al (1995) An improved approach to prepare human brains for research. J Neuropathol Exp Neurol 54:42–56CrossRefPubMed
Metadata
Title
Nodular bilateral amygdala degeneration in demented individuals
Authors
Aurelio Hernandez Lain
Andrew P. Lieberman
Rolf Pfannl
E. Tessa Hedley-Whyte
Publication date
01-11-2010
Publisher
Springer-Verlag
Published in
Acta Neuropathologica / Issue 5/2010
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-010-0745-3

Other articles of this Issue 5/2010

Acta Neuropathologica 5/2010 Go to the issue